首页> Cancer: A Journal of the American Cancer Society> Uterine cancer in Jewish Israeli BRCA1/2 BRCA1/2 mutation carriers

Uterine cancer in Jewish Israeli BRCA1/2 BRCA1/2 mutation carriers

导出原文传递

翻译打印收藏纠错

作者： Laitman Yael ^[1] ; Michaelson‐Cohen Rachel ^[2] ; Levi Einat ^[3] ; Chen‐Shtoyerman Rakefet ^[4] ; Reish Orit ^[5] ; Josefsberg Ben‐Yehoshua Sagi ^[6] ; Bernstein‐Molho Rinat ^[7] ; Keinan‐Boker Lital ^[8] ; Rosengarten Ora ^[9] ; Silverman Barbara G. ; Perri Tamar ; Korach Jacob ; Mor Pnina ; Ephrat Ben‐Baruch Noa ; Levy Lahad Ephrat ; Friedman Eitan ; the Israeli Consortium of Hereditary Breast Cancer

作者单位： Oncogenetics Unit, Institute of Human Genetics, and Meirav High Risk Clinic, Chaim Sheba Medical ^[1] Department of Gyneco‐OncologySheba Medical CenterTel‐Hashomer,Israel ^[2] Genetics Institute and NOGA High Risk Clinic, Shaare Zedek Medical Center, Hebrew University School ^[3] Oncogenetics Clinic, Clinical Genetics Institute, Kaplan Medical Center, Rehovot, Hebrew University ^[4] Israeli National Cancer Registry, Ministry of Health, Chaim Sheba Medical CenterTel‐Hashomer,Israel ^[5] Gyneco‐Oncology Unit, Institute of Oncology, Shaare Zedek Medical Center, Hebrew University School ^[6] Oncology DepartmentKaplan Medical Center, Rehovot, Hebrew University School of MedicineJerusalem ^[7] Breast Cancer Unit, Oncology Institute, Chaim Sheba Medical CenterTel‐Hashomer,Israel ^[8] Genetics Institute, Assaf Harofe Medical CenterZerifin,Israel ^[9]

关键词 BRCA1/2 germline mutations uterine cancer uterine sarcoma risk reducing surgery Jewish women

发布时间 2019-09-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交